According to PersistenceMarketResearch, the global smart inhalers market will witness a robust CAGR between 2020 and 2030.
The Digital Wave in Healthcare
The simultaneous functioning of mobile applications and smart inhalers for monitoring medication schedules and dosing thereafter is bound to substantiate the smart inhalers market in the near future. Smart inhalers are there for monitoring adherence, precisely recording date, time, and location of every dosage that is administered. Dosage reminders could also be sent. Wireless communication has facilitated sharing of these readings. Also, there are hoards of smart devices available, which could be attached to the inhaler (externally/internally) for those who do not intend discarding traditional inhalers. The smart inhalers well-known in the market of the US include AirDuo Digihaler, ProAir Digihaler, ArmonAir Digihaler, and Hailie.
At the same time, it needs to be noted that pharmacists also need to be digitally benevolent, so as to support healthcare professionals and patients alike. This awareness will certainly affirm the growth of smart inhalers market in the upcoming period.
Request for sample article: https://www.persistencemarketresearch.com/samples/26881
How is the market Categorized?
Smart inhalers, by type of product, span metered dose inhalers, inhalers, dry powder inhalers, and nebulizers. The application areas include COPD and asthma. By distribution channel it’s retail pharmacies, online pharmacies, and hospitals. Online pharmacies have been doing the rounds due to the convenience factor involved therein.
North America holds the largest market share due to immediate adoption of smart treatment for respiratory disorders. Europe is second-seeded. The Asia-Pacific is expected to witness a double-digit CAGR between 2020 and 2030. This could be credited to emphasis being laid on health expenditure, especially by the countries like China and India. The other factors include rapid industrialization coupled with economic growth.
The key market participants include H&T Presspart Manufacturing Ltd., AstraZeneca plc, Aptar Pharma, Teva Pharmaceuticals, Findair Sp. Z.o.o., Zeolr Technologies Pvt. Ltd., Vectura Group, and Boehringer Ingelheim. Adherium’s Symbicort inhaler monitoring device for Symbicort aerosol inhaler from AstraZeneca has been benefiting the patients’ respiratory tract’s digital monitoring. Also, Propeller Health, in collaboration with Novartis, has custom add-on sensor to serve Breezhaler inhaler. Seretide Evohaler from GlaxoSmithKline is amongst the well-known built-in dose counters available in the smart inhalers market.